Home › Funds › Knoll Capital Management, LLC › ENTX

Knoll Capital Management, LLC position in ENTX

ENTERA BIO LTD · Health Care

Knoll Capital Management, LLC reported holding 5,881,879 shares of ENTX (ENTERA BIO LTD) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 4.86% of its reported portfolio and ranking #7 among its reported holdings. Knoll Capital Management, LLC has disclosed ENTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.88M sh
Reported value held$10.41M
Portfolio Weight4.86%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Knoll Capital Management, LLC's ENTX position evolved

Knoll Capital Management, LLC first disclosed a stake in ENTX in Q3 2023 at 2,484,275 shares (US$1.8M). The position peaked in Q4 2024 at 5,881,879 shares, worth US$12.5M. Across 12 filings, Knoll Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 5,881,879 shares valued at US$10.4M. Notable position changes include a 56% increase in Q4 2023 (shares rose 178% over the following quarter), a 52% increase in Q4 2024 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.48M $1.80M New
Q4 2023 3.88M $2.33M Add
Q1 2024 3.88M $6.48M Hold
Q2 2024 3.88M $7.14M Hold
Q3 2024 3.88M $7.38M Hold
Q4 2024 5.88M $12.47M Add
Q1 2025 5.88M $10.00M Hold
Q2 2025 5.88M $11.18M Hold
Q3 2025 5.88M $11.29M Hold
Q4 2025 5.88M $11.41M Hold
Q1 2026 5.88M $6.47M Hold
Q2 2026 5.88M $10.41M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENTX and 13F data

ENTX (ENTERA BIO LTD) is a Health Care company. 29 other funds we track also report a position in ENTX — the largest reported positions include BVF INC/IL (US$4.3M), Gem Investment Advisors, LLC (US$34K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENTX

All ENTX fund holders →

FAQ

How long has Knoll Capital Management, LLC held ENTX?

Knoll Capital Management, LLC has disclosed ENTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Knoll Capital Management, LLC's current position in ENTX?

As of Q2 2026, Knoll Capital Management, LLC holds 5.88M shares of ENTX (ENTERA BIO LTD), valued at $10.41M, representing 4.86% of its reported portfolio and ranking #7.

Has Knoll Capital Management, LLC been buying or selling ENTX?

In the latest 13F filing (Q2 2026), Knoll Capital Management, LLC held unchanged its position in ENTX. The position peaked in Q4 2024 at 5.88M shares.

Which other funds hold ENTX?

Other major institutional holders of ENTX include BVF INC/IL, Gem Investment Advisors, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.